Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation.
Article Details
- CitationCopy to clipboard
LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD
Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation.
Mol Endocrinol. 1990 Dec;4(12):1806-14. doi: 10.1210/mend-4-12-1806.
- PubMed ID
- 1707125 [ View in PubMed]
- Abstract
In this study we report the preparation of a human osteosarcoma cell cDNA library and describe the isolation and sequence determination of a clone encoding the complete sequence of a novel human insulin-like growth factor (IGF)-binding protein (hIGFBP-4). Previous work indicated that hIGFBP-4 is the predominant IGFBP expressed by human osteoblast-like cells, and that IGFBP-4 binds and inhibits the mitogenic activities of IGF-I and IGF-II. Sequence determination revealed that hIGFBP-4 is a unique gene product with significant amino- and carboxy-terminal sequence similarity to three other known IGFBPs. Identical alignment of 18 cysteines in IGFBP-4 and the three other IGFBPs is a key structural feature of this protein family. In vitro studies of human osteoblast-like cells suggest that PTH regulates the expression of hIGFBP-4 and that the PTH effect is mediated through a cAMP mechanism. hIGFBP-4 mRNA was also expressed in skin fibroblasts, and thus, this inhibitory IGFBP could be an important physiological regulator of IGF actions in bone cells and other cell types as well.